Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Maria Lattanzi

Comparison of Half and Full Doses of an MF59-adjuvanted Cell Culture-Derived a/H1N1v Vaccine in Japanese Children

Advances in Therapy

Medicine

Pharmacology

2010

English

Patterns of Macrolide Resistance Determinants Among Community-Acquired Streptococcus Pneumoniae Isolates Over a 5-Year Period of Decreased Macrolide Susceptibility Rates

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1999

English

Related publications

Influenza Vaccination in Children Primed With MF59®-adjuvanted or Non-Adjuvanted Seasonal Influenza Vaccine

Human Vaccines and Immunotherapeutics

English

Cumulative Clinical Experience With MF59-Adjuvanted Trivalent Seasonal Influenza Vaccine in Young Children

International Journal of Infectious Diseases

English

AS03- And MF59-Adjuvanted Influenza Vaccines in Children

Frontiers in Immunology

Allergy

Immunology

2017

English

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults

English

Influenza a/H1n1 MF59 Adjuvanted Vaccine in Pregnant Women and Adverse Perinatal Outcomes: Multicentre Study

British Medical Journal

Medicine

2013

English

Comparison of the Adverse Events Associated With MF59-Adjuvanted and Non-Adjuvanted H1N1 Vaccines in Healthy Young Male Korean Soldiers

Japanese Journal of Infectious Diseases

English

MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine: Pooled Analysis of Safety in Older Adults ≥65 Years of Age

International Journal of Infectious Diseases

English

An Adjuvanted Whole Cell Vaccine as Post-Remission Immunotherapy for Acute Leukemia

English

Preparation of Inactivated Tissue Culture Rabies Vaccine Adjuvanted With Natural Immune Stimulants

Journal of Veterinary Medical Research

2005

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Maria Lattanzi

Comparison of Half and Full Doses of an MF59-adjuvanted Cell Culture-Derived a/H1N1v Vaccine in Japanese Children

Patterns of Macrolide Resistance Determinants Among Community-Acquired Streptococcus Pneumoniae Isolates Over a 5-Year Period of Decreased Macrolide Susceptibility Rates

Related publications

Influenza Vaccination in Children Primed With MF59®-adjuvanted or Non-Adjuvanted Seasonal Influenza Vaccine

Cumulative Clinical Experience With MF59-Adjuvanted Trivalent Seasonal Influenza Vaccine in Young Children

AS03- And MF59-Adjuvanted Influenza Vaccines in Children

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults

Influenza a/H1n1 MF59 Adjuvanted Vaccine in Pregnant Women and Adverse Perinatal Outcomes: Multicentre Study

Comparison of the Adverse Events Associated With MF59-Adjuvanted and Non-Adjuvanted H1N1 Vaccines in Healthy Young Male Korean Soldiers

MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine: Pooled Analysis of Safety in Older Adults ≥65 Years of Age

An Adjuvanted Whole Cell Vaccine as Post-Remission Immunotherapy for Acute Leukemia

Preparation of Inactivated Tissue Culture Rabies Vaccine Adjuvanted With Natural Immune Stimulants